Search

Your search keyword '"Aamdal, S"' showing total 375 results

Search Constraints

Start Over You searched for: Author "Aamdal, S" Remove constraint Author: "Aamdal, S"
375 results on '"Aamdal, S"'

Search Results

2. Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 ‘CREATE’

22. Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3. European Organization for Research and Treatment of Cancer (EORTC) phase 2 trial 90101 'CREATE'

26. Results from a first in man Phase I/II adjuvant Dendritic Cell Vaccine study in high risk prostate cancer patients following radical surgery

29. Late abstracts 186–187

31. Defining the Critical Hurdles in Cancer Immunotherapy

38. Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group

40. hTERT/survivin mRNA-loaded dendritic cell vaccination combined with ex-vivo expanded T cell transfer in stage IV melanoma patients show a longer overall survival in patients with sustained immune responses against hTERT

42. [Gene therapy in cancer]

43. Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b

44. Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG)

45. Defining the Critical Hurdles in Cancer Immunotherapy

46. SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance

47. Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon.

48. Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon.

Catalog

Books, media, physical & digital resources